Mesa Laboratories, Inc. (MLAB) |
| 129.09 0.44 (0.34%) 08-28 16:00 |
| Open: | 127.81 |
| High: | 129.66 |
| Low: | 126.79 |
| Volume: | 153,074 |
| Market Cap: | 722(M) |
| PE Ratio: | 13.03 |
| Exchange: | NASDAQ |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 151.44 |
| Resistance 1: | 129.66 |
| Pivot price: | 117.38 |
| Support 1: | 107.02 |
| Support 2: | 93.03 |
| 52w High: | 129.66 |
| 52w Low: | 58.83 |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| EPS | 0.850 |
| Book Value | 33.710 |
| PEG Ratio | 0.00 |
| Gross Profit | 28.632 |
| Profit Margin (%) | 1.92 |
| Operating Margin (%) | 11.69 |
| Return on Assets (ttm) | 3.3 |
| Return on Equity (ttm) | 2.7 |
Thu, 27 Aug 2026
Former Mesa Labs (NASDAQ: MLAB) officer may sell shares from stock awards - Stock Titan
Fri, 21 Aug 2026
Is Mesa Laboratories Inc (MLAB) Overvalued After 4.5% Rally? GF - GuruFocus
Fri, 21 Aug 2026
Former Mesa Labs (MLAB) exec files notice for August stock sale - Stock Titan
Mon, 17 Aug 2026
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript - The Globe and Mail
Mon, 17 Aug 2026
Mesa Labs (NASDAQ: MLAB) director settles 3,810 RSUs into stock - Stock Titan
Mon, 17 Aug 2026
Mesa Laboratories (NASDAQ: MLAB) director now holds 6,973 shares - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |